We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Sanofi | NASDAQ:SNY | NASDAQ | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.71 | 1.43% | 50.28 | 50.24 | 50.31 | 52,816 | 14:21:57 |
By Cecilia Butini
Sanofi SA said Monday that it would invest in a vaccine production center in Singapore.
The French pharmaceutical major said it is planning to invest 400 million euros ($476.1 million) over five years, and that the new site will allow it to produce vaccines on a massive scale for Asia and to complement exisiting manufacturing capacity in Europe and North America.
The project is expected to create up to 200 local jobs, the company said.
Construction of the plant is expected to being in the third quarter of 2021, with the site becoming fully operational in the first quarter of 2026, Sanofi said.
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
April 12, 2021 01:39 ET (05:39 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Sanofi Chart |
1 Month Sanofi Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions